← Back to patent-cliff list
地诺孕素
Tier C — Watch / tradeDienogest
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：PR
Brand：Visanne、Endometrion、Dinagest
Indications (approved)：避孕、内分泌系统疾病、子宫内膜异位症
Regional status
US
-
EU
无进展
2004-07-01
China
批准上市
2018-12-17
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Dienogest?
Approved indications include: 避孕, 内分泌系统疾病, 子宫内膜异位症.
When does the Dienogest patent expire?
No public expiry year is available for Dienogest yet; this page updates once verified.
How do I get a quote for Dienogest intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25